Northwire Canada EditionTuesday, August 25, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% NVO 0.070 +0.0% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0% GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% NVO 0.070 +0.0% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0%

Healthcare

Page 3
  1. Jun 26, 2026 · 08:45 · MDNA · Routine −

    Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights

    Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights

    01
  2. Jun 26, 2026 · 08:30 · QNTM · Neutral

    Preclinical MS drug developer navigating FDA clinical hold while leveraging consumer supplement royalties.

    NetworkNewsAudio Announces Audio Press Release (APR) the Advancement of First-in-Class Treatment for Multiple Sclerosis

    02
  3. Jun 26, 2026 · 08:30 · ONCO · Neutral

    Canadian preclinical-stage oncology company developing PNKP inhibitor ONC010 and AI-driven SynoGraph platform.

    NetworkNewsAudio Announces Audio Press Release (APR) Discussing the Development of PNKP Inhibitors in Oncology Drug Development

    03
  4. Jun 26, 2026 · 08:10 · VPT · Routine +

    AI cardiac imaging startup scaling niche partnerships while navigating a critical $55k cash balance and negative working capital.

    Ventripoint and Ollie Hinkle Heart Foundation Partner to Expand Access to AI-Powered Heart Imaging for Children Living with Heart Disease

    04
  5. Jun 26, 2026 · 06:45 · VVTM · Routine +

    VVT Med Expands European Commercial Footprint Through Exclusive Distribution Agreement in Greece

    VVT Med Expands European Commercial Footprint Through Exclusive Distribution Agreement in Greece

    05
  6. Jun 25, 2026 · 23:52 · MDX · Routine +

    MedX Health Launches SkinSecure SaaS to Target CRO Market, But Liquidity Crisis and Going Concern Risks Dominate

    MedX Health Launches SkinSecure(TM) to Bring Direct, Non-Invasive, Objective Biological Measurement to Skin Health Research

    06
  7. Jun 25, 2026 · 19:03 · HELP · Routine +

    Helus Pharma closes $50M equity offering to fund Phase 3 MDD readout in Q4 2026, extending cash runway amid leadership transition.

    Cybin closes $50-million (U.S.) offering

    07
  8. Jun 25, 2026 · 18:01 · MDP · Routine +

    GRAFAPEX execution on plan, but +44% run into print prices in the optimism; legacy erosion offsets top-line growth.

    Medexus Announces Fiscal Year 2026 Results, Demonstrating Continued Momentum and Strong Product-Level Performance of GRAFAPEX (treosulfan) for Injection

    08
  9. Jun 25, 2026 · 08:30 · SEGN · Routine +

    Israeli med-tech SaaS expands domestic footprint while navigating severe liquidity constraints and unproven U.S. commercialization.

    Seegnal to Deploy its Medication Safety Platform Across Nazareth Hospital EMMS, Expanding its Israeli Hospital Footprint

    09
  10. Jun 25, 2026 · 08:30 · QNTM · Neutral

    Pre-revenue MS developer navigates FDA clinical hold while doubling down on myelin-repair narrative and consumer-health royalties

    Quantum BioPharma Ltd. (NASDAQ: QNTM) Advancing Innovative, First-in-Class, Patented MS Therapy

    10
  11. Jun 25, 2026 · 08:30 · ONCO · Neutral

    Preclinical PNKP inhibitor developer burns cash and raises capital while marketing AI oncology partnerships to a niche market.

    Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Leading Out in Developing Fresh Wave of Inhibitor Classes

    11
  12. Jun 25, 2026 · 08:01 · BETR · Routine +

    Pre-revenue psychedelic-adjacent biotech secures CAD $2M financing and GMP manufacturing partner for BETR-001 IND filing.

    BetterLife Engages Syner-G to Oversee GMP Manufacturing of BETR-001 for IND and Phase 1

    12
  13. Jun 25, 2026 · 07:30 · BCT · Routine +

    BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT(TM)

    BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT(TM)

    13
  14. Jun 25, 2026 · 07:00 · EDT · Routine +

    Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX

    Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX

    14
← Newer Older →